Additionally, such a model would allow researchers to perform studies on signaling mechanisms of NPFF to gain new insights into the nature of anorexigenic effects of NPFFR2 and to evaluate the therapeutic potential of NPFFR2 as an anti-obesity target. The gene discussed is NPFF; the disease is obesity due to melanocortin 4 receptor deficiency.